|
gptkbp:instanceOf
|
medical condition
|
|
gptkbp:affects
|
glucose metabolism
|
|
gptkbp:associatedWith
|
gptkb:polycystic_ovary_syndrome
gptkb:type_2_diabetes
gptkb:metabolic_syndrome
obesity
|
|
gptkbp:canBeExacerbatedBy
|
sedentary lifestyle
sleep deprivation
high sugar intake
|
|
gptkbp:canBeReversedBy
|
lifestyle modification
bariatric surgery
|
|
gptkbp:cause
|
genetic factors
physical inactivity
hyperglycemia
chronic stress
hyperinsulinemia
high-fat diet
|
|
gptkbp:diagnosedBy
|
gptkb:oral_glucose_tolerance_test
fasting insulin test
|
|
gptkbp:firstDescribed
|
gptkb:Wilhelm_Falta
1929
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Insulin resistance
|
|
gptkbp:improves
|
exercise
weight loss
dietary changes
|
|
gptkbp:involves
|
impaired insulin signaling
|
|
gptkbp:measures
|
glucose tolerance test
HOMA-IR
|
|
gptkbp:occurredIn
|
gptkb:Cushing's_syndrome
pregnancy
acromegaly
|
|
gptkbp:prevalence
|
adults
children
|
|
gptkbp:relatedTo
|
insulin sensitivity
beta cell dysfunction
|
|
gptkbp:riskFactor
|
gptkb:cardiovascular_disease
nonalcoholic fatty liver disease
|
|
gptkbp:treatment
|
gptkb:metformin
gptkb:thiazolidinediones
|
|
gptkbp:bfsParent
|
gptkb:P48736
|
|
gptkbp:bfsLayer
|
6
|